The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Abbott announced that the FDA approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation ...
read more
Pfizer Inc. and Genmab A/S announced that the FDA approved the supplemental Biologics License Application (sBLA) granting full approval for TIVDAK® (...
read more
The FDA has taken action aimed at helping to ensure the safety and effectiveness of laboratory developed tests, or LDTs, which are used in a growing ...
read more
Ractigen Therapeutics, announced that the FDA approved the company's Investigational New Drug (IND) application for RAG-01, a groundbreaking saRNA ...
read more
Amgen announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a ...
read more
AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been recommended for approval in the European Union (EU) for the ...
read more
Lonza announced the launch of its AI-enabled Route Scouting Service offering. The offering aims to streamline synthetic route identification for novel...
read more
Walgreens is expanding its specialty pharmacy services and investing in its capabilities as the company further grows its core pharmacy business to ...
read more
Multiply Labs, a robotics company developing automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corporation (...
read more
Amneal Pharmaceuticals, Inc. announced the availability of Over the Counter (“OTC”) Naloxone Hydrochloride (Naloxone HCI) Nasal Spray, USP, 4mg, ...
read more
Freedom Biosciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has notified the Company that it may proceed with its FREE001-TRD...
read more
Compass Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to CTX-009, the Company...
read more
Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of ...
read more
XOMA Corporation announced it has earned a $9 million milestone related to the U.S. Food and Drug Administration’s (FDA) approval of Day One ...
read more
Wednesday, April 24, 2024
Endo, Inc., a newly formed entity, announced that it has completed the previously announced acquisition of substantially all of the assets of Endo ...
read more